Raptor Pharmaceutical Corp. (NASDAQ:RPTP) reported its last earnings on Aug 04 AMC (BMO = before market open, AMC= after market close). The company will report its next earnings on Nov 3 – Nov 7 (Est.). The company reported the earnings of $-0.16/Share in the last quarter where the estimated EPS by analysts was $-0.18/share. The difference between the expected and actual EPS was $0.02/share, which represents an Earnings surprise of 11.1%.
Many analysts are providing their Estimated Earnings analysis for Raptor Pharmaceutical Corp. and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $-0.14/share. These analysts have also projected a Low Estimate of $-0.16/share and a High Estimate of $-0.12/share.
In case of Revenue Estimates, 4 analysts have provided their consensus Average Revenue Estimates for Raptor Pharmaceutical Corp. as 34.68 Million. According to these analysts, the Low Revenue Estimate for Raptor Pharmaceutical Corp. is 34 Million and the High Revenue Estimate is 35.7 Million. The company had Year Ago Sales of 25.79 Million.
When it comes to the Analysis of a Stock, Price Target plays a vital role. 6 Analysts reported that the Price Target for Raptor Pharmaceutical Corp. might touch $11 high while the Average Price Target and Low price Target is $7.67 and $4 respectively.
To analyze a stock, one should look for Upgrades and Downgrades of a stock. Raptor Pharmaceutical Corp. got Upgrade on 7-Apr-16 where investment firm JMP Securities Upgrade the stock from Mkt Perform to Mkt Outperform.
Raptor Pharmaceutical Corp. closed its last trading session at $7.49 with the loss of -4.27%. The Market Capitalization of the company stands at 638.92 Million. The Company has 52-week high of $13.3 and 52-week low of $2.94. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 11.44% where SMA50 and SMA200 are 21.45% and 40.28% respectively. The Company Touched its 52-Week High on Sep 3, 2015 and 52-Week Low on Jan 20, 2016.
The Relative Volume of the company is 3.1 and Average Volume (3 months) is 752.1 million. Raptor Pharmaceutical Corp. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.
The company shows its Return on Assets (ROA) value of -25.1%. The Return on Equity (ROE) value stands at -93.3%. While it’s Return on Investment (ROI) value is -21.8%.
While looking at the Stock’s Performance, Raptor Pharmaceutical Corp. currently shows a Weekly Performance of 5.75%, where Monthly Performance is 19.5%, Quarterly performance is 37.88%, 6 Months performance is 68.31% and yearly performance percentage is -40.35%. Year to Date performance value (YTD perf) value is 37.88%. The Stock currently has a Weekly Volatility of 7.70% and Monthly Volatility of 6.30%.